Biotech grants in Australia
Explore Biotech grants for companies in Australia. This list brings together funding for drug discovery, diagnostics, cell and gene therapy, biomanufacturing and life-science research from Australian innovation agencies, research funders and foundations, international programs open to applicants in Australia, and competitions any company can enter, with the deadline, award size and eligibility on every listing. Grants aimed at Biotech in Australia come first.
Showing 25-48 of 354 grants
Export Market Development Grant (EMDG)
🇦🇺Austrade · Australia
Reimburses Australian businesses for a share of their eligible marketing and promotion spend when they sell or plan to sell products overseas.
Export Market Development Grants (EMDG)
🇦🇺Austrade · Australia
Pays Australian exporters and their representative bodies between $20,000 and $80,000 a year in matched funding to market and promote their goods and services in international markets, with the maximum set by their export-readiness tier.
Australia R&D Tax Incentive
🇦🇺ATO · Australia
Funds Australian companies through tax incentives that reward innovation investment and reduce financial risk.
ARC Discovery Early Career Researcher Award
🇦🇺ARC · Australia
Funds three-year fellowships for early-career researchers across all disciplines except medical research with salary and project support.
ARC Discovery Projects
🇦🇺ARC · Australia
Funds Australian university teams developing long-term, university-led research through a two-stage concept pathway.
ARC Future Fellowships
🇦🇺ARC · Australia
Supports four-year fellowships for mid-career researchers in non-medical disciplines aligned with national science priorities.
ARC Linkage Projects
🇦🇺ARC · Australia
Funds Australian universities and industry in co-funded projects with shared research contributions and partnership.
Innovation Booster Grant 2026
🇦🇺DEED · Australia
Funds WA early-stage founders and startups up to $50,000 to commercialise an innovation.
CSIRO On Accelerate
🇦🇺CSIRO · Australia
Supports Australian science-based startups with six-month acceleration, mentorship, and early-stage equity from CSIRO pathways.
GREGoRi Innovation Projects
NIH · United States
Funds a genuinely new experimental or computational approach to finding the cause of a rare genetic disorder, where the current state of the art falls short.
FY26 Reconstructive Transplant Research Program Concept Award
CDMRP · United States
Funds small, high-risk exploratory research into reconstructive transplantation and vascularized composite allotransplantation for wounded Service Members and Veterans.
Xcelerate Champion of Innovation
WHX Tech · United Arab Emirates
Pays an equity-free cash prize to the top healthcare startup pitching live at WHX Tech's Xcelerate competition in Dubai.
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01)
NIH · United States
Funds theory and method development on how genetic and non-genetic factors together produce variation in complex traits, tested against large existing datasets.
Strategic Research Agreement — Round 1
Breakthrough T1D · United States
Funds investigator-led type 1 diabetes research partnerships across preclinical discovery, treatment, and translational priorities.
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01)
NIH · United States
Funds new analysis of clinical, genomic, environmental and registry data that already exists, to sharpen who is at risk of cancer and what happens to them.
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research
NIH · United States
Funds the development and hard technical validation that turns a working cancer research technology into one other laboratories will actually adopt.
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research
NIH · United States
Funds proof-of-concept work on a genuinely new tool, assay, platform or instrument for characterising cancer cells or handling biospecimens.
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21)
NIH · United States
Funds the same reanalysis of already-collected cancer data on a smaller, exploratory footing, for teams that do not need a full research project award.
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant
NIH · United States
Funds exploratory studies of the ethical, legal and social consequences of human genetics, especially where a technology or a use of genomic data is new.
Ethical, Legal and Social Implications (ELSI) Research
NIH · United States
Funds a full research project on the ethics, law and social effects of human genetics — and refuses to review an application with no diverse-perspectives plan.
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD)
NIH · United States
Funds one bundled run from first-in-human through phase 2a for a dementia drug that works on something other than amyloid or tau.
Lupus Insight Prize
LRA · United States
Provides prize recognizing a specific significant recent lupus research discovery through the Lupus Insight Prize.
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21)
NIH · United States
Funds the exploratory version of the same theory-and-methods work on complex trait variation, for ideas that need testing before a larger project is justified.
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01)
NIH · United States
Funds work on how GLP-1 and related drugs change cancer risk — raising it for some cancers, lowering it for others.